• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    All News #Library
    Biotech

    SynbioTech Launches SYNMUE for Immunosenescence at Probiota

    PR NEWSWIRE

    Ractigen Presents saRNA as Obesity Treatment Frontier at ADA`26

    PR NEWSWIRE

    Novo`s Zenagamtide Achieves 14.6% Weight Loss in T2D at ADA 2026

    PR NEWSWIRE

    Lundbeck Presents Positive Phase IIb Data for Bocunebart at AHS

    PR NEWSWIRE

    Lupin Receives FDA Approval for Ranluspec (Ranibizumab)

    PR NEWSWIRE

    Cabaletta Shares Rese-cel, PC-Free Lupus Data at EULAR

    FIERCE BIOTECH

    Aurobindo Enters Biologics CDMO with Rs 1,200-Cr Plant

    ECONOMICTIMES

    ADC Therapeutics` Ph3: ZYNLONTA + Rituximab Results in r/r DLBCL

    PR NEWSWIRE

    Race for a Bundibugyo Ebola Vaccine: From Failure to Preparedness

    FIRSTWORD PHARMA

    How Biotech Companies Are Surviving and Thriving With DEI Efforts

    BIOSPACE

    Oban BioPharma Unveils OBT-676, 1st-in-Class DACRA/Triple-G Drug

    GLOBENEWSWIRE

    Terrestrial Wins $2.2M Massachusetts Grant to MAP Manufacturing

    FIRSTWORD PHARMA

    Vivex: VIA Disc Cuts Opioid Use in Lumbar Discogenic Pain Study

    GLOBENEWSWIRE

    Washington`s Biotech China Hawks Gain Ground in Policy Debate

    ENDPOINTS

    Industry Leaders: Next FDA Chief Must Champion Gene Therapies

    BIOSPACE

    Aptahem to Present at IOPC 2026 Conference in Athens, Greece

    FIRSTWORD PHARMA

    CicadaBio Announces Oral Presentation on CC-18 at ADA 2026

    BUSINESSWIRE

    ZUPREME-1 Ph2 Data Back Petrelintide for Weight Management at ADA

    GLOBENEWSWIRE

    UroGen Pharma Issues Inducement Grants on Nasdaq

    GLOBENEWSWIRE

    Structure Therapeutics: Nature Medicine Covers Aleniglipron Ph 2b

    GLOBENEWSWIRE

    SINOVAC Files 2025 Annual Report with Unaudited Financial Results

    FIRSTWORD PHARMA

    Hengrui and Kailera Present Ribupatide Clinical Data at ADA 2026

    GLOBENEWSWIRE

    Onco-Innovations Signs LOI with Nanosoft to ONC010 Program

    ACCESSWIRE

    MSCRF Awards Lentigen Grant to Commercialize Sickle Cell Cure

    FIRSTWORD PHARMA

    Mezzion Pharma Clears FUEL-2 Phase 3 Regulatory Milestone

    PR NEWSWIRE

    Memo Therapeutics Shares Ph2 Potravitug Data at ERA Congress 2026

    GLOBENEWSWIRE

    Suven Life Sees Positive Interim Review for Ph 3 Alzheimer`s Drug

    INDPHARMAPOST

    MannKind`s Afrezza Highlight Pediatric & Pregnancy Use at ADA

    GLOBENEWSWIRE

    Kura Oncology Reports Inducement Grants on Nasdaq

    GLOBENEWSWIRE

    Jade Bio Closes Public Offering with Full Underwriter Exercise

    GLOBENEWSWIRE

    Intellia Therapeutics Reports Inducement Grants on Nasdaq

    GLOBENEWSWIRE

    Insulet Unveils Latest Enhancements to Omnipod Insulin System

    FIERCE BIOTECH

    InnoCare`s Orelabrutinib Ph IIb SLE Data Presented at EULAR 2026

    GLOBENEWSWIRE

    Hemogenyx Pharmaceuticals Announces Annual General Meeting Notice

    ACCESSWIRE

    Fulcrum Cuts Most of Staff as Seres Extends Cash Runway into 2027

    ENDPOINTS

    Foghorn Therapeutics Joins Goldman Sachs 47th Health Conference

    GLOBENEWSWIRE

    Roche Details Gazyva`s Win in Autoimmune Kidney Disease Study

    FIRSTWORD PHARMA

    Roche Incretin Shows Promise in Mid-Stage Type 1 Diabetes Trial

    ENDPOINTS

    Vcare`s Eratrectinib Gets Marketing Approval as Next-Gen TRK Drug

    PR NEWSWIRE

    Eos SENOLYTIX: PTC-2105 Boosts Muscle Mass in Preclinical Data

    GLOBENEWSWIRE

    EnGeneIC Wins 2026 Breakthrough in Glioblastoma Biotech Award

    GLOBENEWSWIRE

    Lilly and Novo Clash at ADA 2026 as Rivals Chase Obesity Market

    BIOSPACE

    Edesa Bio: Paridiprubart Shows Positive Results in Kidney Injury

    GLOBENEWSWIRE

    Diakonos Shares GBM Data, Unveils Melanoma Study at ASCO 2026

    PR NEWSWIRE

    Cosmos Health Launches Oliv18 in U.S. for Cardiovascular Support

    GLOBENEWSWIRE

    Climb Bio Shares CLYM116 Phase 1 Safety Data at ERA Congress 2026

    GLOBENEWSWIRE

    Clearmind to Share CMND-100 Psychedelic Trial Insights on Webinar

    GLOBENEWSWIRE

    Boan Biotech Out-Licenses Dulaglutide Injection for U.S. Market

    FIRSTWORD PHARMA

    Biomea Presents Icovamenib at ADA`26, Expands Ph I BMF-650 Study

    GLOBENEWSWIRE

    FDA Backs CardiAMP HF II Path to Approval for Ischemic HFrEF

    GLOBENEWSWIRE

    Finerenone Cuts Kidney Progression & CV Risk Across CKD Patients

    PRESS RELEASE

    Bayer Pursues Wider Label After Kerendia`s Non-Diabetic CKD Win

    PRESS RELEASE

    Azafaros Publishes Phase 2 RAINBOW Data for Nizubaglustat

    BUSINESSWIRE

    Arcutis Biotherapeutics Reports Inducement Grants on Nasdaq

    GLOBENEWSWIRE

    Amneal: Phase 4 ELEVATE-PD Data Reinforce CREXONT in Parkinson

    GLOBENEWSWIRE

    Altesa BioSciences Shares Phase 2 Vapendavir Data at ASM 2026

    PR NEWSWIRE

    Affibody Revives Izokibep, Seeks New Partner After Acelyrin Exit

    FIERCE BIOTECH

    Addex Holds Annual General Meeting 2026

    GLOBENEWSWIRE

    Azitra Adjourns 2026 Annual Meeting, Announces Reconvened Date

    PR NEWSWIRE

    MTF Biologics Expands FlexHD Portfolio with New Meshed Product

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.